TL;DRBunkerhill Health closed a Series B led by Khosla Ventures, taking total funding to $55m, to scale Carebricks, a platform that lets health systems build and deploy their own clinical AI agents rather than buying vendor point-tools. The angle: agentic AI is moving from passive documentation to taking action, triaging, prioritising and routing patients, with 20+ agents live at UTMB. The piece foregrounds the caveats: the outcome metrics are company-supplied, single-institution and unaudited, only some algorithms are FDA-cleared, and clinical autonomy raises liability and oversight questions.
A healthcare AI startup has raised fresh funding to push AI agents deeper into hospital operations. Bunkerhill Health closed a Series B led by Khosla Ventures, bringing total funding to $55m, HIT Consultant reports.
The pitch is a platform, not a product. Its Carebricks system lets health systems build and run their own AI agents, rather than buying fragmented tools from vendors.
From documentation to action
This is the shift worth watching. Most healthcare AI so far has drafted notes and summarised records, sitting passively beside the clinician.
